Immunosuppression for interstitial lung disease in systemic sclerosis

被引:18
作者
Cappelli, Susanna [1 ]
Guiducci, Serena [1 ]
Randone, Silvia Bellando [1 ]
Cerinic, Marco Matucci [1 ]
机构
[1] Univ Florence, DENOthe Ctr, Dept Biomed, Div Rheumatol, Viale Pieraccini 18, I-50139 Florence, Italy
关键词
D O I
10.1183/09059180.00001813
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The efficacy of immunosuppressors in the treatment of systemic sclerosis-interstitial lung disease is still matter of controversy. In this review we will analyse the evidence that immunosuppressors, despite not being able to reverse fibrotic changes, may help in slowing disease progression. Induction treatment with cyclophosphamide should be started as soon as possible in patients at risk for progression. Mycophenolate mofetil and rituximab have to be considered in patients who are unable to tolerate cyclophosphamide. After remission, maintenance treatment with mycophenolate mofetil or azathioprine should be started in order to preserve the benefits achieved during the induction treatment.
引用
收藏
页码:236 / 243
页数:8
相关论文
共 73 条
[1]   Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort [J].
Assassi, Shervin ;
Sharif, Roozbeh ;
Lasky, Robert E. ;
McNearney, Terry A. ;
Estrada-Y-Martin, Rosa M. ;
Draeger, Hilda ;
Nair, Deepthi K. ;
Fritzler, Marvin J. ;
Reveille, John D. ;
Arnett, Frank C. ;
Mayes, Maureen D. .
ARTHRITIS RESEARCH & THERAPY, 2010, 12 (05)
[2]  
Avouac J, 2009, ANN RHEUM DIS, V68, P620
[4]   Oral cyclophosphamide improves pulmonary function in scleroderma patients with fibrosing alveolitis: experience in one centre [J].
Beretta, Lorenzo ;
Caronni, Monica ;
Raimondi, Massimo ;
Ponti, Alessandra ;
Viscuso, Tiziana ;
Origgi, Laura ;
Scorza, Raffaella .
CLINICAL RHEUMATOLOGY, 2007, 26 (02) :168-172
[5]  
Berezne A, 2008, J RHEUMATOL, V35, P1064
[6]   Phase I/II trial of autologous stem cell transplantation in systemic sclerosis:: procedure related mortality and impact on skin disease [J].
Binks, M ;
Passweg, JR ;
Furst, D ;
McSweeney, P ;
Sullivan, K ;
Besenthal, C ;
Finke, J ;
Peter, HH ;
van Laar, J ;
Breedveld, FC ;
Fibbe, VE ;
Farge, D ;
Gluckman, E ;
Locatelli, F ;
Martini, A ;
van den Hoogen, F ;
van de Putte, L ;
Schattenberg, AVN ;
Arnold, R ;
Bacon, PA ;
Emery, P ;
Espigado, I ;
Hertenstein, B ;
Hiepe, F ;
Kashyap, A ;
Kötter, I ;
Marmont, A ;
Martinez, A ;
Pascual, MJ ;
Gratwohl, A ;
Prentice, HG ;
Black, C ;
Tyndall, A .
ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (06) :577-584
[7]   B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial [J].
Bosello, Silvia ;
De Santis, Maria ;
Lama, Gina ;
Spano, Cristina ;
Angelucci, Cristiana ;
Tolusso, Barbara ;
Sica, Gigliola ;
Ferraccioli, Gianfranco .
ARTHRITIS RESEARCH & THERAPY, 2010, 12 (02)
[8]   Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome [J].
Bouros, D ;
Wells, AU ;
Nicholson, AG ;
Colby, TV ;
Polychronopoulos, V ;
Pantelidis, P ;
Haslam, PL ;
Vassilakis, DA ;
Black, CM ;
du Bois, RM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (12) :1581-1586
[9]  
Daoussis D, 2012, CLIN EXP RHEUMATOL, V30, pS17
[10]   Is There a Role for B-cell Depletion as Therapy for Scleroderma? A Case Report and Review of the Literature [J].
Daoussis, Dimitrios ;
Liossis, Stamatis-Nick C. ;
Tsamandas, Athanassios C. ;
Kalogeropoulou, Christina ;
Kazantzi, Alexandra ;
Korfiatis, Panagiotis ;
Yiannopoulos, Georgios ;
Andonopoulos, Andrew P. .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2010, 40 (02) :127-136